tirzepatide vs semaglutide side effects which has fewer or Semaglutide Vs. Zepbound: Weight Loss Differences, Side Effects & Dosage Tirzepatide vs Semaglutide: Which is

This "start now, switch if approved" approach means you're not waiting weeks to begin treatment

Sources Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland Novo Nordisk March 2, 2026 Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America Novo Nordisk January 5, 2026

Can GLP-1 help improve conditions beyond weight loss

For context, diarrhoea is reported in approximately 916% of patients taking semaglutide 2.4 mg (Wegovy) according to its UK Summary of Product Characteristics (SmPC, emc), and in a broadly similar range for tirzepatide (Mounjaro) per its UK SmPC